12:00 AM
 | 
Jul 09, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Dificid fidaxomicin regulatory update

Optimer said Health Canada approved Dificid fidaxomicin to treat Clostridium difficile infection (CDI) in adults. The company said Dificid is already available in Canada. Dificid is approved to treat C. difficile-associated diarrhea (CDAD) in the U.S. and the...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >